0.5 ML omalizumab-igec 150 MG/ML Prefilled Syringe
- RxCUI
- 2726010
- RxNorm name
- 0.5 ML omalizumab-igec 150 MG/ML Prefilled Syringe
- Display name
- 0.5 ML omalizumab-igec 150 MG/ML Prefilled Syringe
- Full name
- 0.5 ML omalizumab-igec 150 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OMLYCLO | OMALIZUMAB-IGEC | CELLTRION USA, Inc. | dbd8709f-1636-45d9-ba94-5a3bc5f22f84 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 2726010 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a2075490-d8e7-4c23-8b2e-8f2cd5a67948 | omalizumab-igec 75 MG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML omalizumab-igec 150 MG/ML Prefilled Syringe [SCD] · omalizumab-igec 75 MG per 0.5 ML Prefilled Syringe [SY] | 3 | 4 | These highlights do not include all the information needed to use OMALIZUMAB-IGEC safely and effectively. See full prescribing information for OMALIZUMAB-IGEC. OMALIZUMAB-IGEC injection, for subcutaneous use Initial U.S. Approval: 2025 Omalizumab-igec is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product and that there are no clinically meaningful differences between the | 20251205 |